NCT06481007

Brief Summary

Cholecystectomy, the surgical removal of the gallbladder, is a common procedure performed to treat benign gallbladder diseases such as cholelithiasis (gallstones), cholecystitis (inflammation of the gallbladder), and biliary dyskinesia. While generally considered safe, this surgery can be associated with significant morbidity and mortality, particularly in certain populations or healthcare settings. Understanding these outcomes and the factors influencing them is crucial for improving patient care and surgical practices. In Algeria, the healthcare landscape presents unique challenges and opportunities for evaluating surgical outcomes. Limited studies have specifically focused on the morbidity and mortality associated with cholecystectomy in this context. This study aims to fill that gap by providing comprehensive data on 30-day postoperative outcomes following cholecystectomy for benign gallbladder diseases in Algeria. Such data is essential for benchmarking current practices, identifying areas for improvement, and ultimately enhancing patient safety and surgical efficacy.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 1, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2025

Completed
Last Updated

July 1, 2024

Status Verified

June 1, 2024

Enrollment Period

6 months

First QC Date

June 22, 2024

Last Update Submit

June 26, 2024

Conditions

Keywords

AlgeriaCholecystectomymortalitymorbidity30 daysdeterminants

Outcome Measures

Primary Outcomes (2)

  • Evaluate the 30-day mortality and morbidity

    Evaluation of rate of mortality and morbidity at 30 day

    occuring in of before 30 day postopérative période.

  • factors associated with 30-day morbidity and mortality

    determinants of the occurence of complications and mortality on or before 30 day in postopérative period

    occuring in of before 30 day postopérative période.

Secondary Outcomes (3)

  • estimate the incidence of incidental gallbladder cancer discovered during cholecystectomy in Algeria.

    postoperative periode ( during or after surgical procedure)

  • estimate the incidence of bile duct injuries following cholecystectomy for benign diseases

    occuring in of before 30 day postopérative periode.

  • assess surgical practices related to cholecystectomy in Algeria.

    During surgical procedure ( Cholecystectomy)

Study Arms (1)

Cholecystectomy

patient opérated ( cholecystectomy) and responding to inclusion criteria

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of patients aged 18 years and older who undergo cholecystectomy for benign gallbladder diseases in Algeria. This includes patients who have their gallbladders removed due to conditions such as gallstones, cholecystitis, biliary dyskinesia and any other benign pathology

You may qualify if:

  • Patients aged 18 years and older.
  • Undergoing cholecystectomy.
  • Surgery performed in public or private hospitals in Algeria.
  • Surgery performed from January 1, 2025, to June 30, 2025.

You may not qualify if:

  • Patients younger than 18 years.
  • Patients refusing to participate.
  • Cholecystectomy performed for Gallbladder cancer.
  • Cholecystectomies performed in conjunction with other major surgeries.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

GallstonesPolypsBiliary DyskinesiaCholecystitis

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsCommon Bile Duct DiseasesBile Duct Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 22, 2024

First Posted

July 1, 2024

Study Start

January 1, 2025

Primary Completion

July 1, 2025

Study Completion

July 2, 2025

Last Updated

July 1, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

we are not going to share data , but the study will be published in an open acces journal.